Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
Anti-Infective Agents
Anti-Infective Agents
/
HBV
HBV
HBV
Products (21)
(2R,3S)-glycosmisic acid
CAS No.:
443908-19-8
Linerixibat
CAS No.:
1345982-69-5
Selgantolimod
CAS No.:
2004677-13-6
Punicalagin
CAS No.:
65995-63-3
Inarigivir Soproxil
CAS No.:
942123-43-5
Erythrocentaurin
CAS No.:
50276-98-7
Taribavirin hydrochloride
CAS No.:
40372-00-7
Niranthin
CAS No.:
50656-77-4
Alamifovir
CAS No.:
193681-12-8
Bersacapavir
CAS No.:
1638266-40-6
3'-Fluoro-2',3'-dideoxyguanosine
CAS No.:
92562-88-4
Ruzotolimod
CAS No.:
1948241-60-8
Vonafexor
CAS No.:
1192171-69-9
Besifovir dipivoxil
CAS No.:
441785-26-8
Linvencorvir
CAS No.:
1808248-05-6
Canocapavir
CAS No.:
2137847-19-7
Viramidine
CAS No.:
119567-79-2
Pradefovir
CAS No.:
625095-60-5
Firzacorvir
CAS No.:
2243747-96-6
Bicyclol
CAS No.:
118159-48-1
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact